Jungang Xie

57.5k total citations · 1 hit paper
109 papers, 3.7k citations indexed

About

Jungang Xie is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Jungang Xie has authored 109 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 37 papers in Physiology and 33 papers in Molecular Biology. Recurrent topics in Jungang Xie's work include Asthma and respiratory diseases (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers) and Pediatric health and respiratory diseases (16 papers). Jungang Xie is often cited by papers focused on Asthma and respiratory diseases (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers) and Pediatric health and respiratory diseases (16 papers). Jungang Xie collaborates with scholars based in China, Canada and United States. Jungang Xie's co-authors include Jianping Zhao, Xiansheng Liu, Min Xie, Min Zhou, Cong Zhang, Ying Zhou, Junqing Yue, Zhiguo Zhang, Shuyun Xu and Ke Wang and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Jungang Xie

104 papers receiving 3.6k citations

Hit Papers

Risk factors for severity and mortality in adult COVID-19... 2020 2026 2022 2024 2020 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jungang Xie China 26 1.3k 846 723 634 561 109 3.7k
Xiansheng Liu China 23 1.3k 1.0× 843 1.0× 715 1.0× 765 1.2× 376 0.7× 122 3.4k
Xiaochen Li China 21 1.3k 1.0× 687 0.8× 714 1.0× 498 0.8× 235 0.4× 68 3.1k
Ying Yao China 30 2.0k 1.5× 442 0.5× 857 1.2× 918 1.4× 301 0.5× 110 4.6k
Alessandro Giuseppe Fois Italy 31 647 0.5× 1.3k 1.5× 544 0.8× 430 0.7× 568 1.0× 135 3.5k
Jianhua Mao China 24 1.5k 1.1× 573 0.7× 834 1.2× 1.0k 1.6× 190 0.3× 184 4.1k
Andrea Bianco Italy 40 727 0.5× 1.7k 2.0× 375 0.5× 910 1.4× 1.2k 2.1× 142 5.5k
Pietro Pirina Italy 33 458 0.3× 1.6k 1.8× 421 0.6× 315 0.5× 1.3k 2.3× 154 3.9k
Jin-Ling Tang China 23 906 0.7× 927 1.1× 200 0.3× 470 0.7× 269 0.5× 73 3.4k
Mohammadreza Ardalan Iran 33 679 0.5× 422 0.5× 242 0.3× 850 1.3× 225 0.4× 281 3.9k

Countries citing papers authored by Jungang Xie

Since Specialization
Citations

This map shows the geographic impact of Jungang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jungang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jungang Xie more than expected).

Fields of papers citing papers by Jungang Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jungang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jungang Xie. The network helps show where Jungang Xie may publish in the future.

Co-authorship network of co-authors of Jungang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Jungang Xie. A scholar is included among the top collaborators of Jungang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jungang Xie. Jungang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fu, Hao, Qian Huang, & Jungang Xie. (2025). Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies. Cells. 14(23). 1874–1874.
4.
Zhan, Yuan, Jiaheng Zhang, Shanshan Chen, et al.. (2025). Arylsulfatase K attenuates airway epithelial cell senescence in COPD by regulating parkin-mediated mitophagy. Redox Biology. 86. 103793–103793. 2 indexed citations
5.
Zhan, Yuan, Shanshan Chen, Jiaheng Zhang, et al.. (2025). Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation. Advanced Science. 12(18). e2415007–e2415007. 1 indexed citations
6.
Wang, Shanshan, et al.. (2025). Role of lysine lactylation in neoplastic and inflammatory pulmonary diseases (Review). International Journal of Molecular Medicine. 55(5). 1–18. 6 indexed citations
7.
Zhan, Yuan, Qian Huang, Shanshan Chen, et al.. (2024). DNA hypomethylation-mediated upregulation of GADD45B facilitates airway inflammation and epithelial cell senescence in COPD. Journal of Advanced Research. 68. 201–214. 7 indexed citations
8.
Wu, Xiaojie, et al.. (2023). Mucus hypersecretion in chronic obstructive pulmonary disease: From molecular mechanisms to treatment. Journal of Translational Internal Medicine. 11(4). 312–315. 6 indexed citations
9.
Zhan, Yuan, Jinkun Chen, Shanshan Chen, et al.. (2022). Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease. Respiratory Research. 23(1). 120–120. 18 indexed citations
10.
Luo, Lijuan, Nian Liu, Yahong Chen, et al.. (2019). Prospective development of practical screening strategies for diagnosis of asthma–COPD overlap. Respirology. 25(7). 735–742. 4 indexed citations
11.
Zhao, Junling, Miao Li, Zhihua Wang, et al.. (2019). Role of PM2.5 in the development and progression of COPD and its mechanisms. Respiratory Research. 20(1). 120–120. 123 indexed citations
12.
Chen, Huilong, Zhen‐Li Huang, Bohua Fu, et al.. (2018). Aberrantly expressed lncRNAs identified by microarray analysis in CD4+T cells in asthmatic patients. Biochemical and Biophysical Research Communications. 503(3). 1557–1562. 16 indexed citations
13.
Xu, Yuzhu, et al.. (2017). GLCCI1 rs37973. Medicine. 96(52). e9442–e9442. 11 indexed citations
14.
Zhao, Junling, Xiaopei Cao, Ya-Li Huang, et al.. (2017). Association of polymorphisms in TLR2 and TLR4 with asthma risk. Medicine. 96(35). e7909–e7909. 27 indexed citations
15.
Chen, Huilong, Xiang-Qin Xu, Sheng Cheng, et al.. (2016). CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response. Experimental and Therapeutic Medicine. 11(5). 1865–1870. 25 indexed citations
16.
Zhou, Yun, Huizhen Sun, Jungang Xie, et al.. (2015). Urinary Polycyclic Aromatic Hydrocarbon Metabolites and Altered Lung Function in Wuhan, China. American Journal of Respiratory and Critical Care Medicine. 193(8). 835–846. 99 indexed citations
17.
Chen, Huilong, Sheng Cheng, Aili Wang, et al.. (2015). IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation.. PubMed Central. 8(7). 10640–5. 7 indexed citations
18.
Shang, Jin, Junling Zhao, Junling Zhao, et al.. (2015). Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation. Biochemistry and Cell Biology. 93(4). 359–366. 22 indexed citations
19.
Hu, Weihua, Jungang Xie, Jianping Zhao, et al.. (2008). Involvement of Bcl-2 Family in Apoptosis and Signal Pathways Induced by Cigarette Smoke Extract in the Human Airway Smooth Muscle Cells. DNA and Cell Biology. 28(1). 13–22. 25 indexed citations
20.
Xu, Yongjian, et al.. (2003). [Polymorphism of interleukin-10 gene promoter and its association with susceptibility to chronic obstructive pulmonary disease in Chinese Han people].. PubMed. 20(6). 504–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026